Quarter Results07.08.2025 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate ...

Conference/Quarter ResultsConference call on the results for the 3rd quarter 2024/2025 (ending 30 June 2025) on 14 August 2025 07.08.2025 / 12:12 CET/CESTThe issuer is solely responsible for the ...

It's Rotten Weed."This is the height of hypocrisy," said Duane Boise, CEO MMJ. "DEA bureaucrats are blocking clean cannabis grown in a DEA inspected cultivation facility, while contaminated products ...

The global brachytherapy market is set to witness a growth rate of ~7% in the next 5 years. Rising global cancer burden, ...

The global cell and gene therapy market is experiencing significant expansion, driven by rising approvals and advancements in ...

Overview of Healthcare Analytics MarketThe Global Healthcare Analytics Market is valued at USD 42.96 Billion in 2024 and is ...

According to Acumen Research and Consulting, the Optical Genome Mapping Market is poised for explosive growth, surging from ...

The biosimilars market represents a transformative segment within the global pharmaceutical industry, offering highly similar ...

Overview of Acute Repetitive Seizures MarketThe global Acute Repetitive Seizures Market is valued at USD 3.2 Billion in 2024 ...

Overview of Circulating Tumor Cells MarketThe Global Circulating Tumor Cells (CTC) Market is a rapidly evolving segment in ...

Almirall (BME: ALM), a global biopharmaceutical company focused on medical dermatology, and Absci Corporation (Nasdaq: ABSI), ...

SGLT2 Inhibitors in Prediabetes Management Market to Reach $980 Million by 2025, Driven by Growing Focus on Early Diabetes Intervention Global Market Poised for 13% CAGR Through 2032 Amid Rising ...